Over the past 12 months, AEON Biopharma insiders bought $243,455 of stock on the open market (1.15Mn shares) and made no open-market sales.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Timothy P Lynch | TenPercentOwner | 6,500,000 | 0 | 6,500,000 | 34.7% | 21 Aug, 2026 |
| 2 | Robert E. Bancroft | President Ceo | 3,177,103 | 0 | 3,177,103 | 17.0% | 19 Feb, 2026 |
| 3 | Chad Oh | Chief Medical Officer | 2,183,436 | 0 | 2,183,436 | 11.7% | 11 Mar, 2026 |
| 4 | Alexander Blair Wilson | Clo, Cso, And Corp Secretary | 2,183,005 | 0 | 2,183,005 | 11.7% | 05 Mar, 2026 |
| 5 | Jennifer Sy | Principal Accounting Officer | 1,501,176 | 0 | 1,501,176 | 8.0% | 05 Mar, 2026 |
| 6 | Marc Forth | Chief Exectuive Officer | 973,231 | 0 | 973,231 | 5.2% | 22 Jun, 2026 |
| 7 | John Bencich | Chief Financial Officer | 754,717 | 0 | 754,717 | 4.0% | 03 Apr, 2026 |
| 8 | Jost Fischer | Director | 489,469 | 0 | 489,469 | 2.6% | 22 Jun, 2026 |
| 9 | Robert J Palmisano | Director | 258,705 | 0 | 258,705 | 1.4% | 22 Jun, 2026 |
| 10 | Eric G Carter | Director | 258,705 | 0 | 258,705 | 1.4% | 22 Jun, 2026 |
| 11 | Shelley B Thunen | Director | 258,705 | 0 | 258,705 | 1.4% | 22 Jun, 2026 |
| 12 | Sponsor, Llc Priveterra | TenPercentOwner | 95,841 | 97,079 | 192,920 | 1.0% | 26 Jul, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 19 Aug, 2026 | Timothy P Lynch | TenPercentOwner | Acquired P | 1,150,000 | $0.21 | $243.46K | 6,500,000 | Direct |
| 17 Jun, 2026 | Marc Forth | Director | Acquired A | 222,684 | $0.00 | $0 | 973,231 | Direct |
| 17 Jun, 2026 | Eric G Carter | Director | Acquired A | 222,684 | $0.00 | $0 | 258,705 | Direct |
| 17 Jun, 2026 | Jost Fischer | Director | Acquired A | 222,684 | $0.00 | $0 | 489,469 | Direct |
| 17 Jun, 2026 | Robert J Palmisano | Director | Acquired A | 222,684 | $0.00 | $0 | 258,705 | Direct |
| 17 Jun, 2026 | Shelley B Thunen | Director | Acquired A | 222,684 | $0.00 | $0 | 258,705 | Direct |
| 02 Apr, 2026 | John Bencich | Chief Financial Officer | Acquired A | 754,717 | $0.00 | $0 | 754,717 | Direct |
| 17 Feb, 2026 | Chad Oh | Chief Medical Officer | Acquired A | 862,500 | $0.00 | $0 | 866,564 | Direct |
| 04 Mar, 2026 | Chad Oh | Chief Medical Officer | Acquired A | 1,316,872 | $0.00 | $0 | 2,183,436 | Direct |
| 17 Feb, 2026 | Jennifer Sy | Principal Accounting Officer | Acquired A | 575,000 | $0.00 | $0 | 575,251 | Direct |
| 17 Feb, 2026 | Alexander Blair Wilson | Clo, Cso, And Corp Secretary | Acquired A | 862,500 | $0.00 | $0 | 866,133 | Direct |
| 04 Mar, 2026 | Alexander Blair Wilson | Clo, Cso, And Corp Secretary | Acquired A | 1,316,872 | $0.00 | $0 | 2,183,005 | Direct |
| 04 Mar, 2026 | Jennifer Sy | Principal Accounting Officer | Acquired A | 925,925 | $0.00 | $0 | 1,501,176 | Direct |
| 17 Feb, 2026 | Robert E. Bancroft | President Ceo | Acquired A | 3,000,000 | $0.00 | $0 | 3,177,103 | Direct |
| 21 May, 2025 | Alexander Blair Wilson | Exec Vp, Clo Corp Secretary | Acquired A | 1,316,872 | $0.00 | $0 | 1,316,872 | Direct |
| 21 May, 2025 | Jennifer Sy | Chief Accounting Officer | Acquired A | 925,925 | $0.00 | $0 | 925,925 | Direct |
| 21 May, 2025 | Marc Forth | Director | Acquired A | 370,370 | $0.00 | $0 | 370,370 | Direct |
| 21 May, 2025 | Robert J Palmisano | Director | Acquired A | 308,641 | $0.00 | $0 | 308,641 | Direct |
| 21 May, 2025 | Chad Oh | Chief Medical Officer | Acquired A | 1,316,872 | $0.00 | $0 | 1,316,872 | Direct |
| 21 May, 2025 | Shelley B Thunen | Director | Acquired A | 308,641 | $0.00 | $0 | 308,641 | Direct |